Viewing Study NCT03652233


Ignite Creation Date: 2025-12-25 @ 3:00 AM
Ignite Modification Date: 2026-03-06 @ 9:34 AM
Study NCT ID: NCT03652233
Status: WITHDRAWN
Last Update Posted: 2019-06-20
First Post: 2018-08-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Afatinib and Nivolumab as Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
Sponsor: Vanderbilt-Ingram Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module